17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Tuesday<br />

10.00 - 10.20 Late breaking news I<br />

318 <strong>Programme</strong> <strong>Book</strong><br />

Can Zometa prevent bone metastases in high risk prostate cancer patients? First Results of the Zometa<br />

European Study (ZEUS).<br />

M. Wirth, Dresden (DE)<br />

Prostate cancer in China<br />

Y-H. Sun, Shanghai (CN)<br />

10.20 - 10.40 State-of-the-art lecture Is there a role for intermittent androgen deprivation?<br />

T.L.J. Tammela, Tampere (FI)<br />

10.40 - 11.20 Debate High risk PC: Surgery vs radiation vs systemic therapy<br />

Moderator: M. Jewett, Toronto (CA)<br />

Surgery: H. Van Poppel, Leuven (BE)<br />

Radiation: A. Bossi, Villejuif (FR)<br />

Systemic therapy: P. Iversen, Copenhagen (DK)<br />

Aims and objectives<br />

The optimal management for men presenting with high risk prostate cancer remains controversial.<br />

Experts will debate the merits of radical prostatectomy, radiation therapy and systemic therapy alone or in<br />

combination. At the end of the session, the delegates will better understand how to personalize the care of<br />

the individual patient presenting with this life threatening disease to achieve the best chance of cure while<br />

minimizing the burden of treatment.<br />

11.20 - 11.35 Late breaking news II<br />

Swedish Registry Study<br />

P. Wiklund, Stockholm (SE)<br />

11.35 - 12.15 Debate Why focal therapy instead of active surveillance for low risk prostate cancer<br />

Moderator: F.C. Hamdy, Oxford (GB)<br />

Pro: M. Emberton, London (GB)<br />

Con: M. Wirth, Dresden (DE)<br />

12.15 - 12.35 Report on the Consensus Statement for Prostate Cancer Prevention<br />

J. Cuzick, London (GB)<br />

12.35 - 13.05 Update European PSA screening<br />

ERSPC perspective<br />

J.E. Hugosson, Göteborg (SE)<br />

Aims and objectives<br />

Screening for prostate cancer is controversial. While a large randomized study has shown a benefit<br />

of screening in terms of prostate cancer mortality. Generally accepted evidence on a proper balance on<br />

advantages and disadvantages is lacking. The purpose of this session will be to inform on the present status<br />

of screening and proper decision taking.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!